COMPASS Pathways plc
CMPS·Stocks·Biotechnology·United Kingdom·Nasdaq·USD
Price
$11.98
Today
+4.6%
YTD
+74.1%
About
COMPASS Pathways PLC is a mental healthcare enterprise based in Cheshire, UK. It explores the application and efficacy of mental healthcare medications. The company's first research programme investigates the impact of psilocybin on treatment-resistant depression. Operating in the US and the UK, COMPASS Pathways was established in 2020. It is listed on the NASDAQ GS under the CMPS ticker. Buy CMPS stock to diversify your eToro investment portfolio.
Price chart
Closing price history for CMPS (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.51
P/S (TTM)0.00
P/B (TTM)18.62
Market cap$1.61B
Cap tierSmall-cap
Industry avg P/E-2.16
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-329.72%
ROA-102.08%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$4.62
Free cash flow$-160.76M
Total debt$54.63M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.43
Employees156
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.